Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (5,735,144)	$ (7,051,367)
Adjustment to reconcile net loss to net cash used in operating activities:
Stock based compensation	626,990	751,821
Interest accrued on note receivable	(27,219)	(26,717)
Write-off of construction-in-process		747,348
Depreciation and amortization	140,183	123,167
Changes in operating assets and liabilities:
Research and development tax incentive receivable	128,442	(24,906)
Prepaid assets and other current assets	298,311	685,328
Accounts payable	707,429	426,756
Accrued liabilities	697,840	(4,430)
Deferred revenue	39,000	25,000
Operating lease obligation	(20,098)	(17,783)
Net cash used in operating activities	(3,144,266)	(4,365,783)
Cash flows from financing activities:
Sales of common stock through ATM	12,584
Payment of offering costs in connection with ATM	(15,000)	(17,920)
Sale of common stock and warrants through direct offering, net of offering costs	903,555
Net cash used in financing activities	901,139	(17,920)
Effect of exchange rate changes on cash and cash equivalents	(23,056)	(12,253)
Net change in cash and cash equivalents	(2,266,183)	(4,395,956)
Cash and cash equivalents at beginning of period	5,478,113	16,612,315
Cash and cash equivalents at end of period	3,211,930	12,216,359
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest	$ 15,325